Pharmaceuticals – Top 5 Emerging Markets Industry Guide

reportlinker.com/p0191854/Pharmaceuticals—Top-5-Emerging-Markets-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2007-16 12

Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2007-11 13

Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2011-16 14

Table 8: Pfizer Inc.: key facts 28

Table 9: Pfizer Inc.: key financials ($) 29

Table 10: Pfizer Inc.: key financial ratios 29

Table 11: GlaxoSmithKline Plc: key facts 31

Table 12: GlaxoSmithKline Plc: key financials ($) 32

Table 13: GlaxoSmithKline Plc: key financials () 33

Table 14: GlaxoSmithKline Plc: key financial ratios 33

Table 15: Aspen Pharmacare Holdings Ltd: key facts 35

Table 16: Aspen Pharmacare Holdings Ltd: key financials ($) 36

Table 17: Aspen Pharmacare Holdings Ltd: key financials (ZAR) 36

Table 18: Aspen Pharmacare Holdings Ltd: key financial ratios 36

Table 29: Ach Laboratrios Farmacuticos S.A.: key facts 53

Table 30: Medley Indstria Farmacutica Ltd: key facts 54

Table 31: Sanofi: key facts 55

Table 32: Sanofi: key financials ($) 56

Table 33: Sanofi: key financials (€) 56

Table 34: Sanofi: key financial ratios 56

Table 35: EMS Sigma Pharma: key facts 58

Table 46: Pfizer Inc.: key facts 74

Table 47: Pfizer Inc.: key financials ($) 75

Table 48: Pfizer Inc.: key financial ratios 75

Table 49: AstraZeneca PLC: key facts 77

Table 50: AstraZeneca PLC: key financials ($) 78

Table 51: AstraZeneca PLC: key financial ratios 79

Table 52: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 81

Table 63: Dr. Reddy’s Laboratories Limited: key facts 97

Table 64: Dr. Reddy’s Laboratories Limited: key financials ($) 98

Table 65: Dr. Reddy’s Laboratories Limited: key financials (Rs.) 98

Table 66: Dr. Reddy’s Laboratories Limited: key financial ratios 98

Table 67: Cipla Limited: key facts 100

Table 68: Cipla Limited: key financials ($) 101

Table 69: Cipla Limited: key financials (Rs.) 101

Table 70: Cipla Limited: key financial ratios 101

Table 71: Ranbaxy Laboratories Limited: key facts 103

Table 72: Ranbaxy Laboratories Limited: key financials ($) 104

Table 73: Ranbaxy Laboratories Limited: key financials (Rs.) 104

Table 74: Ranbaxy Laboratories Limited: key financial ratios 104

Table 75: Lupin Limited: key facts 106

Table 76: Lupin Limited: key financials ($) 107

Table 77: Lupin Limited: key financials (Rs.) 107

Table 78: Lupin Limited: key financial ratios 108

Table 89: Eli Lilly and Company: key facts 125

Table 90: Eli Lilly and Company: key financials ($) 126

Table 91: Eli Lilly and Company: key financial ratios 126

Table 92: Pfizer Inc.: key facts 128

Table 93: Pfizer Inc.: key financials ($) 129

Table 94: Pfizer Inc.: key financial ratios 129

Table 95: GlaxoSmithKline Plc: key facts 131

Table 96: GlaxoSmithKline Plc: key financials ($) 132

Table 97: GlaxoSmithKline Plc: key financials () 133

Table 98: GlaxoSmithKline Plc: key financial ratios 133

SOURCE Reportlinker